$0.00

Injectable Drug Delivery Market

Name: Injectable Drug Delivery Market
SKU: 1602
Availability: InStock

Category: Healthcare

Report Preview

The global injectable drug delivery market size was valued at USD 561.0 million in 2021 and is projected to reach up to 1,223.0 million in 2030, with a CAGR of 9.0% in the forecasted period. The rising prevalence of cancer, increasing incidences of chronic diseases are driving the market growth. Moreover, the rise in biologics market is also among the prominent factors for the market growth in the forecasted period.

Attribute	Key Insights
Estimated Market Value (2021)	561 USD million
Forecasted Market Value (2028)	1223 USD million
CAGR % 2023-2028	9.0%`
Leading Region	North America

Type Insights

The devices segment accounted largest revenue share in 2021. The growing prevalence of chronic disorders is leading to an increase in overall syringe practice, predominantly disposable syringes. The cardiovascular illnesses, diabetes, and obesity have been found to be leading causes of death from chronic disorders. As populace surge is believed to be the critical factor in emerging nations, this is likely to have the highest impact all around the world.

Therapeutic Application Insights

The auto-immune diseases segment hold the largest revenue share in 2021. The immune system bouts and terminates its own body tissue in autoimmune disorders. The diabetes, rheumatoid arthritis, lupus, and other auto-immune diseases are amongst the most frequent diseases. Anti-inflammatory medicines, immune suppressants, and other medicines have been approved to treat auto-immune diseases.

The oncology segment is fastest developing segment of the injectable drugs delivery market in 2021. The rising prevalence of cancer is fuelling the growth of the segment. As per the data of the American Cancer Society, by 2020, there will be around 1,806,590 cancer patients in the U.S. alone, up 31% from 2010.

Distribution Channel Insights

The hospitals segment holds the maximum share in the injectable drugs delivery market in 2021. This is attributed to an increase in the patient’s admitted to hospitals with acute and chronic wounds. Moreover, growth of the segment is also being compelled by the surge in the number of individual clinics in developed and emerging countries.

The retail pharmacy stores segment is predicted to show substantial growth over the forecasted period. The retail pharmacies trade pharmaceutical medications and drugs. These stores provide generic and branded medications, and other pharmaceutical supplies. The increasing preference of patients for purchasing injectable drugs delivery from these stores is boosting the growth of the segment.

Regional Insights

North America is expected to dominate the injectable drugs delivery market in 2021. The rise of injectable drugs delivery market in North America region is being accredited to the rising prevalence of numerous disorders. As per the Alzheimer’s Association, around 6.2 million Americans aged 65 and older will have Alzheimer’s disease by 2020. There are around 3.8 million women and 2.4 million men among those patients. Furthermore, increasing adoption of approaches by market players are also aiding the growth of North America injectable drugs delivery market. For instance, in July 2020, Piramal Critical Care collaborated with Medivant Healthcare, to answer the substantial shortage of injectable medications in hospitals across the nation.

Increased R&D investments, government initiatives to increase awareness about chronic diseases, and rise in healthcare spending are some of the factors that are driving the growth of the injectable drug delivery market in these regions.

Europe, is predicted to grow at the fastest rate during the forecasted period. The UK holds the largest share in the injectable drugs delivery market in Europe region. The Europe injectable drugs delivery market is attributed to the factors such as the rise of the biologics market, increasing incidence of chronic disorders, and the growing demand for self-injection devices are all contributing to this trend. The other factors impelling the growth of injectable drugs delivery market in Europe region are escalating disposable income, growing number of partnerships, and increasing awareness about safety and comfort.

However, a considerably large patient pool in the Asia Pacific region will provide probable growth openings for players in the injectable drug delivery market.

Key Companies Insights

Key players are aiming on their technological partnerships, collaborations, and merger & acquisitions strategies to gain an economical edge and grow their product portfolio & business footmarks. The Covid-19 pandemic hindered the healthcare systems worldwide and driven the market players to transform products for unexploited opportunities. Some of the key players operating in the global injectable drug delivery market include:

BD
Pfizer Inc.
Teva Pharmaceuticals Industries Ltd.
Eli Lilly and Company
Baxter International, Inc.
Sandoz
Terumo
Schott AG
Gerresheimer
Ypsomed
Bespak
Braun Melsungen
Other players

Some of the Recent Developments:

In 2016, Biocon launched its disposable pen product in Japan, which will be distributed by its partner Fujifilm Pharma throughout the country.
In March 2015, BD bought CareFusion Corporation to expand its capabilities and improve drug management and patient safety. In the same year, BD purchased CRISI Medical Systems, a medical technology business, in order to improve the efficiency of drug delivery via IV injectable. BD has a worldwide presence in 50 nations, allowing it to maintain its position in the global market.
In June 2020, Pfenex Inc. announced that Alvogen, its commercialization partner, had launched Teriparatide Injection in the U.S. for a variety of indications, including postmenopausal women with osteoporosis who are at high risk of broken bones.
In 2014, Terumo Corporation partnered with Ypsomed Group. The organization combined their prefillable polymer syringe, PLAJEX, with YpsoMate as a result of this agreement. This aided the corporation in strengthening their syringe product offerings.
In 2015, Sanford-Burnham Medical Research Institute and Eli Lilly and Company formed a partnership to discover immunological therapeutics for inflammatory bowel disorder, lupus, and autoimmune diseases. The expertise of both institutions will be pooled to discover novel treatments for these disorders.

Segments

By Type

Devices
- Conventional Injectables
- Pre-Filled Syringes
- Auto-Injectors
- Pen-Injectors
Formulations

By Formulation Packaging

Ampules
Vials
Cartridges
Bottles

By Therapeutic Application

Auto-immune diseases
Hormonal Disorders
Orphan Diseases
Oncology
Others

By Usage Pattern

Curative Care
Immunization
Other

By Site of Administration

Skin
Circulatory/Musculoskeletal
Organs
Central Nervous System

By Distribution Channel

Hospitals & Clinics
Retail Pharmacy Stores
Others

By Facility of Use

Hospitals & Clinics
Home Care Settings
Other

By Geography

North America
- S.
- Canada
- Mexico
Europe
- K.
- Germany
- France
- Italy
- Spain
- Russia
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- ASEAN
Latin America
- Brazil
- Argentina
- Colombia
MEA
- South Africa
- Saudi Arabia
- UAE

Egypt

- Objectives of the Study
- Global Injectable Drug Delivery Scope and Market Estimation
  - Global Injectable Drug Delivery Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 – 2032)
  - Global Injectable Drug Delivery Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 – 2032
- Market Segmentation
  - Type of Global Injectable Drug Delivery
  - Formulation Packaging of Global Injectable Drug Delivery
  - Therapeutic Application of Global Injectable Drug Delivery
  - Site of Administration of Global Injectable Drug Delivery
  - Usage Pattern of Global Injectable Drug Delivery
  - Distribution Channel of Global Injectable Drug Delivery
  - Facility of Use of Global Injectable Drug Delivery
  - Region of Global Injectable Drug Delivery

Executive Summary
Market Factor Analysis
- Global Injectable Drug Delivery Industry Trends under COVID-19 Outbreak
  - Global COVID-19 Status Overview
  - Influence of COVID-19 Outbreak on Global Injectable Drug Delivery Industry Development
- Market Dynamics, By Region
  - Drivers
  - Limitations
  - Opportunities
  - Impact Analysis of Drivers and Restraints
- Ecosystem / Value Chain Analysis
  - Raw Materials / Components Suppliers
  - Manufacturers / Vendors
  - Distributors
  - Buyers / End-users
  - Forward Integration & Backward Integration of Key Stakeholders
- Global Injectable Drug Delivery – Pricing Trends Analysis & Average Selling Prices (ASPs)
- End-User / Customer Preferences & Consumer Surveys
- Technology Roadmap & Key Innovations /Developments
- Key Mandates & Regulatory Scenario Analysis
- Patents Landscape
- Manufacturing Cost Structure Share Analysis
- Key Mergers & Acquisitions, Expansions, JVs, Funding / VCs, etc.
- Porter’s Five Forces Analysis
  - Bargaining Power of Suppliers
  - Bargaining Power of Buyers
  - Threat of Substitutes
  - Threat of New Entrants
  - Competitive Rivalry
- PEST Analysis
  - Political Factors
  - Economic Factors
  - Social Factors
  - Technological Factors
- SWOT Analysis
- Russia-Ukraine War Impacts Analysis
- ANSOFF Matrix
  - Market Penetration Strategy
  - Product Development Strategy
  - Market Development Strategy
  - Diversification Strategy
- Inflation Impacts Analysis
  - Supply Side Impacts
  - Demand Side Impacts
  - Outlook in 2023 & Beyond
- Market Investment Feasibility Analysis
- Opportunity Map Analysis
- Market Investment Opportunity Analysis (Top Investment Pockets), By Segments & By Regions
Global Injectable Drug Delivery Estimates & Historical Trend Analysis (2019 – 2022)
Global Injectable Drug Delivery Estimates & Forecast Trend Analysis, by Type
- Global Injectable Drug Delivery Revenue (US$ Mn) Estimates and Forecasts, by Ty, 2019 to 2032
  - Devices
  - Formulations

Global Injectable Drug Delivery Estimates & Forecast Trend Analysis, by Formulation Packaging
- Global Injectable Drug Delivery Revenue (US$ Mn) Estimates and Forecasts, Formulation Packaging 2019 to 2032
  - Ampules
  - Vials
  - Cartridges
  - Bottles

Global Injectable Drug Delivery Estimates & Forecast Trend Analysis, by Therapeutic Application
- Global Injectable Drug Delivery Revenue (US$ Mn) Estimates and Forecasts, Therapeutic Application 2019 to 2032
  - Auto-immune diseases
  - Hormonal Disorders
  - Orphan Diseases
  - Oncology
  - Others

Global Injectable Drug Delivery Estimates & Forecast Trend Analysis, by Usage Pattern
- Global Injectable Drug Delivery Revenue (US$ Mn) Estimates and Forecasts, Usage Pattern 2019 to 2032
  - Curative Care
  - Immunization
  - Other

Global Injectable Drug Delivery Estimates & Forecast Trend Analysis, by Site of Administration
- Global Injectable Drug Delivery Revenue (US$ Mn) Estimates and Forecasts, Site of Administration 2019 to 2032
  - Skin
  - Circulatory/Musculoskeletal
  - Organs
  - Central Nervous System

Global Injectable Drug Delivery Estimates & Forecast Trend Analysis, by Distribution Channel
- Global Injectable Drug Delivery Revenue (US$ Mn) Estimates and Forecasts, Distribution Channel 2019 to 2032
  - Hospitals & Clinics
  - Retail Pharmacy Stores
  - Others

Global Injectable Drug Delivery Estimates & Forecast Trend Analysis, by Region
- Global Antibody-Drug Conjugates Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2032
  - North America
  - Europe
  - Asia Pacific
  - Middle East & Africa
  - South America

North America Injectable Drug Delivery : Estimates & Forecast Trend Analysis
- North America Antibody-Drug Conjugates Market Assessments & Key Findings
  - Injectable Drug Delivery Introduction
  - Injectable Drug Delivery Size Estimates and Forecast (US$ Million) (2019 – 2031)
    - By Type
    - By Formulation Packaging
    - By Therapeutic Application
    - By Usage Pattern
    - By Site of Administration
    - By Distribution Channel
    - By Country
      - The U.S.
      - Canada
      - Mexico

Europe Injectable Drug Delivery : Estimates & Forecast Trend Analysis
- Europe Injectable Drug Delivery Assessments & Key Findings
  - Injectable Drug Delivery Introduction
  - Injectable Drug Delivery Size Estimates and Forecast (US$ Million) (2019 – 2031)
    - By Type
    - By Formulation Packaging
    - By Therapeutic Application
    - By Usage Pattern
    - By Site of Administration
    - By Distribution Channel
    - By Country
      - Germany
      - K.
      - France
      - Italy
      - Spain
      - Russia
      - Rest of Europe

Asia Pacific Injectable Drug Delivery : Estimates & Forecast Trend Analysis
- Asia Pacific Market Assessments & Key Findings
  - Injectable Drug Delivery Introduction
  - Injectable Drug Delivery Size Estimates and Forecast (US$ Million) (2019 – 2031)
    - By Type
    - By Formulation Packaging
    - By Therapeutic Application
    - By Usage Pattern
    - By Site of Administration
    - By Distribution Channel
    - By Country
      - China
      - Japan
      - India
      - Australia
      - South Korea
      - ASEAN
      - Rest of Asia Pacific

Middle East & Africa Injectable Drug Delivery : Estimates & Forecast Trend Analysis
- Middle East & Africa Market Assessments & Key Findings
  - Injectable Drug Delivery Introduction
  - Injectable Drug Delivery Size Estimates and Forecast (US$ Million) (2019 – 2031)
    - By Type
    - By Formulation Packaging
    - By Therapeutic Application
    - By Usage Pattern
    - By Site of Administration
    - By Distribution Channel
    - By Country
      - A.E.
      - Saudi Arabia
      - Egypt
      - South Africa
      - Rest of Middle East & Africa

South America Injectable Drug Delivery : Estimates & Forecast Trend Analysis
- South America Market Assessments & Key Findings
  - Injectable Drug Delivery Introduction
  - Injectable Drug Delivery Size Estimates and Forecast (US$ Million) (2019 – 2031)
    - By Type
    - By Formulation Packaging
    - By Therapeutic Application
    - By Usage Pattern
    - By Site of Administration
    - By Distribution Channel
    - By Country
      - Brazil
      - Argentina
      - Colombia
      - Rest of South America

Competition Landscape
- Injectable Drug Delivery Competition Index, By Leading Players
- Injectable Drug Delivery Competition White Space Analysis, By Application / End-user
- Injectable Drug Delivery Competition Heat Map Analysis, By Products / Services / Solutions
- Injectable Drug Delivery Competition Regional Intensity Map Analysis, By Geographies Served
- Injectable Drug Delivery Concentration & Company Market Shares (%) Analysis, 2022
- Injectable Drug Delivery Competition Quadrant Analysis, By Leading Players / Innovators / Emerging Players / New Entrants
Company Profiles
- BD
  - Company Overview & Key Stats
  - Financial Performance & KPIs
  - Product / Service / Solutions Portfolio & Applications / End-uses
  - Business Strategy & Recent Developments

* Similar details would be provided for all the players mentioned below

Pfizer Inc.
Teva Pharmaceuticals Industries Ltd.
Eli Lilly and Company
Baxter International, Inc.
Sandoz
Terumo
Schott AG
Gerresheimer
Ypsomed
Bespak
Braun Melsungen
Others

Research Methodology
- External Sources / Databases
- Internal Proprietary Database
- Primary Research
- Secondary Research
- Assumptions
- Limitations
- Report FAQs
Research Findings & Conclusion

Quick Contact

+13217109863

info@markettreeresearch.com

Injectable Drug Delivery Market

Report Preview

ToC

Related products

Compression Therapy Market

Diabetes Care Products Market

Molecular Diagnostics Market

Antineoplastic Drugs Market